Illumina (NASDAQ: ILMN) and Synergetics USA (NASDAQ:SURG) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation.


This table compares Illumina and Synergetics USA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Illumina 30.34% 19.42% 10.74%
Synergetics USA 7.35% 9.09% 6.45%

Insider and Institutional Ownership

91.6% of Illumina shares are owned by institutional investors. 0.9% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent recommendations for Illumina and Synergetics USA, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Illumina 1 8 11 0 2.50
Synergetics USA 0 0 0 0 N/A

Illumina presently has a consensus price target of $213.71, indicating a potential downside of 11.91%.

Earnings and Valuation

This table compares Illumina and Synergetics USA’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Illumina $2.40 billion 14.77 $462.64 million $5.30 45.77
Synergetics USA N/A N/A N/A $0.18 N/A

Illumina has higher revenue and earnings than Synergetics USA. Synergetics USA is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.


Illumina beats Synergetics USA on 8 of the 8 factors compared between the two stocks.

About Illumina

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company’s portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

About Synergetics USA

Synergetics USA, Inc., formerly Valley Forge Scientific Corp., is a supplier of precision surgical devices. The Company focuses on the surgical disciplines of ophthalmology and neurosurgery. It offers precision engineered disposable and reusable devices, surgical equipment and surgical procedural kits. It also delivers energy modalities for the performance of surgery, including laser energy, ultrasonic energy, radio frequency energy for electro surgery and lesion generation, visible light energy for illumination and simultaneous infusion (irrigation) of fluids into the operative field. Its products include VersaVIT 2.0 Vitrectomy System, Directional II Laser Probe and Pinnacle 360�. It offers its products under the brand names: VersaPACK, Core Essentials, Photon, Solitaire, Volk’s and Labtician’s, among others. It offers approximately 1,000 separate catalogue items in the vitreoretinal surgical market. It sells its products in approximately 60 countries outside the United States.

Receive News & Ratings for Illumina Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina and related companies with's FREE daily email newsletter.